BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1049@pharmaconomics
DTSTAMP:20260707T015840Z
DTSTART;VALUE=DATE:20250630
DTEND;VALUE=DATE:20250701
SUMMARY:INMB Phase 2 — XPro
DESCRIPTION:Phase 2 trial results for XPro in Alzheimer’s disease are due Jun 30\, 2025. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1711754/000121390026008204/ea027431701ex99-1_inmune.htm\n\nTrack it: https://pharmaconomics.com/e/1049
URL:https://pharmaconomics.com/e/1049
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:INMB catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR